During the corresponding time, Venus Concept Inc saw a revenue deteriorated by -10.11 % year on year, sequentially revenue fell by -5.89 %. While revenue at the Venus Concept Inc 's corporate clients
Venus Concept Inc's Comment on Sales, Marketing and Customers
The company sells systems through traditional sales contracts, internal financing programs, and distributors, primarily serving customers in North America and select international markets. In 2024, approximately 26% of aesthetic system revenues were generated from internal financing programs, excluding the ARTAS iX system, which is not offered under these programs. In January 2024, the company introduced the Venus Prime program, a structured in-house financing option for North American customers that replaced the previous subscription program. Venus Prime provides competitive financing rates, payment flexibility, and a technology upgrade program, with monthly payments linked to activation codes to ensure service and warranty compliance. The company collaborates with customers to enhance service quality, patient traffic, and financial returns.
The company's product portfolio includes twelve aesthetic technology platforms, notably the ARTAS and NeoGraft systems for hair restoration, which address a broad market segment. Their medical aesthetic platforms have regulatory clearance for treatments such as facial wrinkles, cellulite reduction, non-invasive fat reduction, and relief of minor muscle aches and pains worldwide. The technology pipeline focuses on improving existing products and developing robotically assisted minimally invasive aesthetic procedures, including the AI.ME platform, which has received FDA 510(k) clearance.
The Venus Concept: Pioneering Aesthetic Medicine Gains Ground with Canadian Approval for Venus Bliss MAX In a world where appearance and self-esteem increasingly shape consumer behavior, the beauty and wellness industry flourishes like never before. At the forefront of this evolving landscape is Venus Concept Inc., a prominent player in the medical aesthetic technology sector, which recently received a significant regulatory green light. Following the initial rollout of its latest innovative device in the United States in early 2022, the Venus Bliss MAX has now earned its medical device license from Health Canada. This pivotal approval opens up new opportunities for the Toronto-based company, and has potenti...
TORONTO, June 3, 2024 - Venus Concept Inc. (NASDAQ: VERO), a global leader in the medical aesthetic technology industry, has taken a significant leap forward in its growth trajectory. The Toronto-based Company proudly announced that it has received a medical device license from Health Canada, authorizing the marketing and distribution of its revolutionary Venus Versa Pro system within Canada. A Milestone for Innovation in Aesthetic MedicineVenus Concept, known for its innovative solutions in the field of medical aesthetics, has been a pivotal force in shaping treatments that combine efficacy with patient safety. The approval of the Venus Versa Pro system by Health Canada marks a new milestone for the Company...
Venus Concept, a global leader in medical aesthetic technology, has recently announced that it has obtained regulatory approval from the State of Israel Ministry of Health for its revolutionary Venus Bliss MAX device. The Venus Bliss MAX was initially launched in the United States in the first quarter of 2022 after receiving clearance from the FDA through its 510(k) process. The device has also been available internationally in approved jurisdictions.The Venus Bliss MAX is a cutting-edge medical aesthetic device that utilizes the power of advanced technology to deliver highly effective treatments. It is designed to address a range of aesthetic concerns, including reducing fat, tightening the skin, and improv...
Venus Concept Announces CE Mark for Venus Versa Pro in EuropeToronto, Feb. 22, 2024 Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global leader in medical aesthetic technology, has just announced that it has been granted the CE Mark from DEKRA Certification B.V. for the market release of the Venus Versa Pro system in the European Union. This significant milestone comes after the successful commercial launch of the device in the United States on November 1, 2023.The CE Mark is a certification indicating that a product complies with the health, safety, and environmental protection standards set by the European Commission. It allows Venus Concept to sell and market the Venus Versa Pro sy...
Venus Concept Inc’s Comment on Sales, Marketing and Customers
The company sells systems through traditional sales contracts, internal financing programs, and distributors, primarily serving customers in North America and select international markets. In 2024, approximately 26% of aesthetic system revenues were generated from internal financing programs, excluding the ARTAS iX system, which is not offered under these programs. In January 2024, the company introduced the Venus Prime program, a structured in-house financing option for North American customers that replaced the previous subscription program. Venus Prime provides competitive financing rates, payment flexibility, and a technology upgrade program, with monthly payments linked to activation codes to ensure service and warranty compliance. The company collaborates with customers to enhance service quality, patient traffic, and financial returns.
The company's product portfolio includes twelve aesthetic technology platforms, notably the ARTAS and NeoGraft systems for hair restoration, which address a broad market segment. Their medical aesthetic platforms have regulatory clearance for treatments such as facial wrinkles, cellulite reduction, non-invasive fat reduction, and relief of minor muscle aches and pains worldwide. The technology pipeline focuses on improving existing products and developing robotically assisted minimally invasive aesthetic procedures, including the AI.ME platform, which has received FDA 510(k) clearance.
Sources:
Venus Concept Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Venus Concept Inc’s corporate clients.
For your research, we’ve provided 9 tables on Venus Concept Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
76.29 %